Evaluation of postoperative quality of life after Billroth-I distal gastrectomy and pylorus-preserving gastrectomy for Stage I gastric cancer

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine0 个研究点目标入组 128 人开始时间: 2016年3月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) pathologically-confirmed gastric cancer (papillary adenocarcinoma, tubular adenocarcinoma, poorly differentiated adenocarcinoma, signet ring cell carcinoma and mucinous adenocarcinoma)
•2) cStage IA or IB, but not T2 tumor at the greater curvature of the stomach
•3) No indication of endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) in a cN0 or cN1case
•4) Patients who underwent EMR or ESD and need additional surgery
•5) Aged 20 to 80 year
•6) PS (ECOG) 0 or 1
•7) No history of gastrointestinal surgery
•8) No history of chemotherapy or radiotherapy
•9) Capability of filling out a survey independently
•10) Provided written informed consent

•1) Synchronous or metachronous malignancies other than carcinoma in situ
•2) Simultaneous surgery other than cholecystectomy
•3) Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator

发起方

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine